# 4D Molecular Therapeutics, Inc.: Form 8-K, filed Jul 2, 2025

- Company: [4D Molecular Therapeutics, Inc.](/companies/fdmt.md) (CIK 1650648)
- Form: 8-K
- Filed: 2025-07-02
- Accepted by EDGAR: Jul 2, 2025, 20:12 ET
- Period: 2025-06-27
- Accession: 0000950170-25-092964
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1650648/000095017025092964/fdmt-20250627.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1650648/000095017025092964/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1650648/000095017025092964/fdmt-20250627.htm

Filed Jul 2, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-092964. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.